Also, our study found a remarkable decrease in plasma ALT in the exercise group and approved a beneficial clinical practice of moderate-intensity continuous exercise in NAFLD patients with diabesity. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.